Literature DB >> 16469958

Metabolic syndrome and the risk of stroke in middle-aged men.

Sudhir Kurl1, Jari A Laukkanen, Leo Niskanen, David Laaksonen, Juhani Sivenius, Kristiina Nyyssönen, Jukka T Salonen.   

Abstract

BACKGROUND AND
PURPOSE: The metabolic syndrome, a clustering of disturbed glucose and insulin metabolism, obesity and abdominal fat distribution, dyslipidemia, and hypertension is associated with cardiovascular diseases. The aim of this study was to examine the relationship of metabolic syndrome, as defined by National Cholesterol Education Program (NCEP) and World Health Organization (WHO) criteria, with the risk for stroke.
METHODS: Population-based cohort study with an average follow-up of 14.3 years from eastern Finland. A total of 1131 men with no history of cardiovascular disease and diabetes at baseline participated. Sixty-five strokes occurred, of which 47 were ischemic strokes.
RESULTS: Men with the metabolic syndrome as defined by the NCEP criteria had a 2.05-fold (95% CI, 1.03 to 4.11; P=0.042) risk for all strokes and 2.41-fold (95% CI, 1.12 to 5.32; P=0.025) risk for ischemic stroke, after adjusting for socioeconomic status, smoking, alcohol, and family history of coronary heart disease. Additional adjustment for ischemic changes during exercise test, serum low-density lipoprotein cholesterol, plasma fibrinogen, energy intake for saturated fats, energy expenditure of leisure time physical activity, and white blood cell count, the results remained significant. The risk ratios among men with metabolic syndrome as defined by the WHO criteria were 1.82 (95% CI, 1.01 to 3.26; P=0.046) for all strokes and 2.16 (95% CI, 1.11 to 4.19; P=0.022) for ischemic stroke. After further adjustment, the respective risks were 2.08 (95% CI, 1.12 to 3.87; P=0.020) and 2.47 (95% CI, 1.21 to 5.07; P=0.013).
CONCLUSIONS: The risk of any stroke is increased in men with metabolic syndrome, in the absence of stroke, diabetes and cardiovascular disease at baseline. Prevention of the metabolic syndrome presents a great challenge for clinicians with respect to stroke.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469958     DOI: 10.1161/01.STR.0000204354.06965.44

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

Review 1.  Migraine and metabolism.

Authors:  G Casucci; V Villani; D Cologno; F D'Onofrio
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  Walking and metabolic syndrome in older adults.

Authors:  Scott Strath; Ann Swartz; Sarah Parker; Nora Miller; Linda Cieslik
Journal:  J Phys Act Health       Date:  2007-10

Review 3.  Impact of metabolic syndrome on cognition and brain: a selected review of the literature.

Authors:  Kathy F Yates; Victoria Sweat; Po Lai Yau; Michael M Turchiano; Antonio Convit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

4.  Metabolic syndrome and physical performance in elderly men: the osteoporotic fractures in men study.

Authors:  Susan A Everson-Rose; Misti Paudel; Brent C Taylor; Tien Dam; Peggy Mannen Cawthon; Erin Leblanc; Elsa S Strotmeyer; Jane A Cauley; Marcia L Stefanick; Elizabeth Barrett-Connor; Kristine E Ensrud
Journal:  J Am Geriatr Soc       Date:  2011-08-01       Impact factor: 5.562

5.  Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes.

Authors:  Shuhan Zhu; Leslie A McClure; Helena Lau; Jose R Romero; Carole L White; Viken Babikian; Thanh Nguyen; Oscar R Benavente; Carlos S Kase; Aleksandra Pikula
Journal:  Neurology       Date:  2015-09-15       Impact factor: 9.910

6.  Increased cerebral oxygen metabolism and ischemic stress in subjects with metabolic syndrome-associated risk factors: preliminary observations.

Authors:  Ken Uchino; Ridwan Lin; Syed F Zaidi; Hiroto Kuwabara; Donald Sashin; Nicholas Bircher; Yue-Fang Chang; Maxim D Hammer; Vivek Reddy; Tudor G Jovin; Nirav Vora; Mouhammad Jumaa; Lori Massaro; Julia Billigen; Fernando Boada; Howard Yonas; Edwin M Nemoto
Journal:  Transl Stroke Res       Date:  2010-09-01       Impact factor: 6.829

Review 7.  White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.

Authors:  Freddy J Alfaro; Anna Gavrieli; Patricia Saade-Lemus; Vasileios-Arsenios Lioutas; Jagriti Upadhyay; Vera Novak
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

8.  Impact of metabolic syndrome components on incident stroke subtypes: a Chinese cohort study.

Authors:  Y-C Chen; C-A Sun; T Yang; C-H Chu; C-H Bai; S-L You; L-C Hwang; C-H Chen; C-Y Wei; Y-C Chou
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

9.  Cyclooxygenase-derived vasoconstriction restrains hypoxia-mediated cerebral vasodilation in young adults with metabolic syndrome.

Authors:  John W Harrell; William G Schrage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

10.  Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment.

Authors:  Byungsu Kim; Sangeok Kim; Roger S McIntyre; Hui Joon Park; Seong Yoon Kim; Yeon Ho Joo
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.